Sumitomo Pharma Co Ltd 2014 Annual Report with Sustainability Disclosures
The report highlights Sumitomo Dainippon Pharma's operational performance for fiscal 2013 (ended March 31, 2014). Consolidated net sales reached ¥387.7 billion, an 11.5% increase year-on-year, supported by strong LATUDA sales in North America. Environmental efforts included reducing total waste generated to 6,085 tons and recording 76,069 tons of energy-related CO2 emissions.
Company: Sumitomo Pharma Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2014
Type: Annual Report with Sustainability Disclosures
Pages: 49
Back to company
Sumitomo Pharma Co Ltd
Annual Report
The report highlights Sumitomo Dainippon Pharma's operational performance for fiscal 2013 (ended March 31, 2014). Consolidated net sales reached ¥387.7 billion, an 11.5% increase year-on-year, supported by strong LATUDA sales in North America. Environmental efforts included reducing total waste generated to 6,085 tons and recording 76,069 tons of energy-related CO2 emissions.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2014
Reporting Period
Apr 1, 2013 - Mar 31, 2014
Fiscal Year
2013
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Employees